Subscribe
This company’s unique structure means its managers are not bound by traditional dividend metrics
With the pandemic well and truly a thing of the past, now is the perfect time to reconsider these unloved assets
This under-priced medical products company is in the ascendancy having overcome destocking issues
This company has been expanding its network and hiking its prices – and growth is expected to increase next year
The airline group is defying market worries about supply chain struggles and a fall in demand
This company has cemented its status as the North Sea's consolidator-in-chief
This fund backs market leaders without forgetting to spread risk
Pub group's share price woes are unfair given its plans to increase cash flow and cut borrowings
Markets are unduly punishing this FTSE 250 trust whose track record in finding gems speaks for itself
The developer has a lot going for it, but the market has cottoned on and the share price may have reached the end of the road
